Skip to main content

Birru Talabi

Feasibility Testing of a Web-Based Reproductive Decision Support Tool for Cystic Fibrosis

MyVoice:CF is acceptable, appropriate, and usable for those with cystic fibrosis (CF). Among a sample of 43 participants, preliminary effectiveness evaluation suggests that MyVoice:CF improves self-efficacy in and frequency of reproductive health communication.
 

Exploring the Effects of Reproductive Health Policy on the Health of People with Rheumatic Diseases

Dr. Mehret Birru Talabi will speak on February 23rd from 12-1 at the Senior Vice Chancellor's Research Seminar! Join for her lecture on Exploring the Effects of Reproductive Health Policy on the Health of People with Rheumatic Diseases.

Register here: https://pitt.zoom.us/webinar/register/WN_QebqJ5IyTY-uK1lsTBWZKA#/registration

How to Provide Sexual and Reproductive Health Care to Patients: Focus Groups with Rheumatologists and Rheumatology Advanced Practice Providers

Join Dr. Mehret Birru Talabi and her colleagues on December 5th for NIH's Behavioral and Social Sciences Research Festival and their presentation on How to Provide Sexual and Reproductive Health Care to Patients: Focus Groups with Rheumatologists and Rheumatology Advanced Practice Providers.

Learn more and register here: https://www.scgcorp.com/OBSSRFestival2023/Agenda

Feasibility Testing of a Web-Based Reproductive Decision Support Tool for Cystic Fibrosis

Dr. Kazmerski , Olivia Stransky, Catherine Wright, Dr. Birru Talabi, Dr. Callegari, Dr. Chang, Dr. Miller, Ashley Deal, Raelynn O'Leary, and Dr. Borrero conducted a study on our femtech tool MyVoice:CF showing that the tool increases self-efficacy and reproductive health communication for those with cystic fibrosis.  

Read more about their findings here: https://pubmed.ncbi.nlm.nih.gov/37833123/